ETC
DFTX

Exchange Traded Concepts’s Definium Therapeutics DFTX Stock Holding History

Exchange Traded Concepts’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,955
Closed -$32.9K – 1228
2022
Q4 		$32.9K Buy
14,955
+10,492
+235% +$29.1K ﹤0.01% 910
2022
Q3 		$16K Buy
4,463
+490
+12% +$4.7K ﹤0.01% 975
2022
Q2 		$38K Buy
3,973
+3,069
+339% +$38.8K ﹤0.01% 945
2022
Q1 		$15K Buy
+904
New +$15.7K ﹤0.01% 1064

Other funds holding DFTX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Exchange Traded Concepts's DFTX Position: Q1 2023 in Review

Exchange Traded Concepts sold out of Definium Therapeutics (DFTX) in Q1 2023, closing a stake of 14,955 shares — an estimated $32.9K sold.

Exchange Traded Concepts first reported a position in DFTX in Q1 2022 and held it in 4 quarters. The position peaked at $38K in Q2 2022. 88 funds tracked by Wall St. Rank hold DFTX as of Q1 2023.

  • Exchange Traded Concepts reported no remaining Definium Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 14,955 Definium Therapeutics shares in Q1 2023, an estimated $32.9K.
  • Exchange Traded Concepts first reported a position in Definium Therapeutics in Q1 2022 and held it in 4 quarters.
  • Exchange Traded Concepts's Definium Therapeutics position peaked at $38K in Q2 2022.
  • 88 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2023.

Based on Exchange Traded Concepts's 13F filing for Q1 2023, filed 12 Apr 2023.